Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE ROLE OF EARLY SECOND TRİMESTER MATERNAL SERUM CADHERİN-6 LEVELS İNTHE PREDİCTİON OF PREECLAMPSİA

NCT07467226 is registered in ClinicalTrials.gov with Samsun University as lead sponsor.

NCT NCT07467226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07467226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE ROLE OF EARLY SECOND TRİMESTER MATERNAL SERUM CADHERİN-6 LEVELS İNTHE PREDİCTİON OF PREECLAMPSİA
Lead sponsor
Samsun University
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
December 30, 2024
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cadherin-6, preeclampsia, pregnancy biomarker